Page last updated: 2024-11-01

niceritrol and Myocardial Infarction

niceritrol has been researched along with Myocardial Infarction in 1 studies

Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.

Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).

Research Excerpts

ExcerptRelevanceReference
"Clofibrate treatment coincided with increasing amounts of monounsaturated fatty acids, especially oleate (18 : 1), in the cholesterol esters, triglycerides and phospholipids while there were significant reductions of the content of linoleic (18 : 2) acid in both the cholesterol esters and triglycerides."2.65Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate but not by niceritrol. ( Boberg, J; Gustafsson, IB; Lithell, H; Vessby, B, 1980)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vessby, B1
Lithell, H1
Gustafsson, IB1
Boberg, J1

Trials

1 trial available for niceritrol and Myocardial Infarction

ArticleYear
Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate but not by niceritrol.
    Atherosclerosis, 1980, Volume: 35, Issue:1

    Topics: Aged; Cholesterol Esters; Clinical Trials as Topic; Clofibrate; Diet Therapy; Dose-Response Relation

1980